解剖病理学市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型、技术、按应用、最终用户、地区和竞争细分

2022 年全球解剖病理学市场价值为 360.9 亿美元，预计在预测期内将强劲增长，到 2028 年CAGR为7.90%。全球解剖病理学市场是医疗保健行业中一个充满活力且至关重要的部门，致力于透过在微观层面上检查组织和细胞来诊断和了解疾病。该市场涵盖广泛的产品和服务，包括实验室测试、诊断设备和相关消耗品。截至 2021 年 9 月我的最后一次知识更新，这是一个正在经历显着成长和创新的行业。

全球解剖病理学市场的主要驱动力之一是全球慢性病和癌症发生率的上升。随着人口老化和生活方式因素的变化，对准确、及时的诊断资讯的需求激增，导致解剖病理学服务的利用率增加。此外，数位病理学和分子诊断等技术的进步提高了病理检测的精确度和效率，进一步推动市场成长。

此外，医疗保健的全球化和远距医疗的采用扩大了解剖病理学服务的范围，允许跨境会诊和病理资料共享。这不仅改善了患者护理，也开闢了市场扩张的新途径。

市场概况
预测期	2024-2028
2022 年市场规模	360.9亿美元
2028 年市场规模	564.9亿美元
2023-2028 年CAGR	7.90%
成长最快的细分市场	药物发现与开发
最大的市场	北美洲

主要市场驱动因素

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：全球解剖病理学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（组织病理学、细胞病理学、外科病理学、其他）
  • 依技术分类（特殊染色、免疫组织化学、电子显微镜、基因检测等）
  • 按应用（疾病诊断、药物发现和开发）
  • 按最终用户（医院、研究实验室、诊断实验室等）
  • 按地区
  • 按公司划分 (2022)
• 市场地图
  • 按类型
  • 依技术
  • 按应用
  • 按最终用户
  • 按地区

第 5 章：亚太地区解剖病理学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国解剖病理学
  • 印度解剖病理学
  • 澳洲解剖病理学
  • 日本解剖病理学
  • 韩国解剖病理学

第 6 章：欧洲解剖病理学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按应用
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 7 章：北美解剖病理学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按最终用户
  • 按应用
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 8 章：南美洲解剖病理学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依技术
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲解剖病理学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 依药物类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非解剖病理学
  • 沙乌地阿拉伯解剖病理学
  • 阿联酋解剖病理学
  • 埃及解剖病理学

第 10 章：市场动态

• 司机
• 挑战

第 11 章：市场趋势与发展

• 最近的发展
• 产品发布
• 併购

第 12 章：全球缺铁性贫血：SWOT 分析

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第14章：竞争格局

• 奎斯特诊断公司
  • Business Overview
  • Company Snapshot
  • Products & Services
  • Current Capacity Analysis
  • Financials (In case of listed)
  • Recent Developments
  • SWOT Analysis
• 丹纳赫公司
• PHC控股公司
• 美国实验室控股公司
• F.霍夫曼-拉罗氏股份公司
• 安捷伦科技公司
• 康德乐健康公司
• 樱花Finetek美国公司
• 新基因组学实验室公司
• 生物基因。

第 15 章：策略建议

第 16 章：关于我们与免责声明

Global Anatomic Pathology Market has valued at USD 36.09 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 7.90% through 2028. The Global Anatomic Pathology Market is a dynamic and vital sector within the healthcare industry, dedicated to the diagnosis and understanding of diseases through the examination of tissues and cells at a microscopic level. This market encompasses a wide range of products and services, including laboratory testing, diagnostic equipment, and related consumables. As of my last knowledge update in September 2021, it was a sector experiencing significant growth and innovation.

One of the primary drivers of the global anatomic pathology market is the rising incidence of chronic diseases and cancer worldwide. With an aging population and changing lifestyle factors, the demand for accurate and timely diagnostic information has surged, leading to increased utilization of anatomic pathology services. Additionally, advancements in technology, such as digital pathology and molecular diagnostics, have enhanced the precision and efficiency of pathology testing, further propelling market growth.

Furthermore, the globalization of healthcare and the adoption of telemedicine have expanded the reach of anatomic pathology services, allowing for remote consultations and the sharing of pathology data across borders. This has not only improved patient care but also opened up new avenues for market expansion.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 36.09 Billion
Market Size 2028	USD 56.49 Billion
CAGR 2023-2028	7.90%
Fastest Growing Segment	Drug Discovery and Development
Largest Market	North America

Key Market Drivers

Rising Incidence of Chronic Diseases and Cancer

The Global Anatomic Pathology Market is experiencing a notable boost due to the rising incidence of chronic diseases and cancer worldwide. This epidemiological trend has become a significant driver in the expansion of the anatomic pathology sector. Chronic diseases, including cardiovascular diseases, diabetes, and respiratory conditions, have been steadily increasing in prevalence, primarily attributed to factors such as aging populations, sedentary lifestyles, and poor dietary choices. Similarly, cancer, one of the most formidable health challenges, continues to grow in frequency, impacting millions of lives globally.

Anatomic pathology plays an indispensable role in the diagnosis and characterization of these diseases. Pathologists examine tissue and cell samples at a microscopic level, providing critical insights into disease progression, staging, and treatment planning. In the context of cancer, precise and timely pathological analysis is essential for determining the type of cancer, its aggressiveness, and the presence of specific biomarkers. This information guides oncologists in developing personalized treatment strategies, such as targeted therapies and immunotherapies, ultimately improving patient outcomes.

As the global healthcare landscape grapples with the increasing burden of chronic diseases and cancer, the demand for anatomic pathology services continues to surge. This heightened demand is not only driven by the sheer volume of cases but also by the need for accurate and comprehensive diagnostic information. Patients and healthcare providers alike are recognizing the pivotal role that anatomic pathology plays in delivering effective and personalized care. Moreover, the integration of technology, such as digital pathology and molecular diagnostics, into anatomic pathology practices has enhanced the precision and efficiency of disease diagnosis. Digital pathology enables the remote viewing and analysis of pathology slides, facilitating consultations and second opinions from experts around the world. Molecular pathology techniques allow for the examination of genetic and molecular alterations within tissues, guiding the development of targeted therapies and immunotherapies.

Technological Advancements

Technological advancements are serving as a powerful catalyst, propelling the Global Anatomic Pathology Market to new heights. This critical healthcare sector, which involves the meticulous examination of tissues and cells at a microscopic level, has undergone a profound transformation thanks to cutting-edge innovations. These advancements are not only enhancing the accuracy and efficiency of anatomic pathology services but also broadening its appeal to healthcare providers and patients alike.

Digital pathology is at the forefront of these technological developments. It allows pathologists to digitize pathology slides, enabling remote viewing, sharing, and analysis. This shift from traditional microscopy to digital platforms has revolutionized pathology practices. Pathologists can collaborate with experts across the globe in real-time, leading to more accurate diagnoses and reducing geographical barriers to accessing expert opinions. Moreover, digital pathology streamlines workflow processes, increases efficiency, and minimizes the risk of human error, ultimately improving patient care.

Automation and artificial intelligence (AI) are also key contributors to the market's growth. Automated slide scanners can process large volumes of slides rapidly, freeing up pathologists' time for more complex tasks. AI algorithms can assist in the identification of abnormalities, further reducing diagnostic errors and increasing the speed of diagnosis. These technologies not only improve diagnostic precision but also enhance the overall cost-effectiveness of anatomic pathology services.

Molecular diagnostics is another area where technology has made significant inroads. This sub-discipline of anatomic pathology involves the examination of genetic and molecular alterations in tissues. Advances in molecular pathology techniques have enabled the detection of specific genetic markers and mutations, guiding targeted therapies and personalized treatment plans. The ability to identify these molecular signatures has revolutionized cancer diagnosis and treatment, ushering in an era of precision medicine. Furthermore, the integration of data analytics and big data in anatomic pathology has opened up new avenues for research and diagnostic insights. Pathologists can leverage vast datasets to identify trends, correlations, and predictive markers, contributing to a deeper understanding of disease mechanisms and progression..

Molecular Diagnostics

Molecular diagnostics has emerged as a powerful force driving the growth of the Global Anatomic Pathology Market. This specialized branch of anatomic pathology involves the examination of genetic and molecular alterations within tissues and cells, and its impact on the field has been transformative. Molecular diagnostics has become an invaluable tool in understanding and managing diseases, particularly in the context of cancer, and it continues to reshape the landscape of anatomic pathology.

One of the key ways in which molecular diagnostics contributes to the growth of the market is through its role in personalized medicine. By analyzing specific genetic and molecular markers within tissues, pathologists can provide precise information about a patient's disease. This information allows clinicians to tailor treatment plans to the individual, selecting therapies that are most likely to be effective while minimizing side effects. The ability to offer personalized treatment options not only improves patient outcomes but also increases the demand for molecular pathology services.

Furthermore, molecular diagnostics plays a pivotal role in cancer diagnosis and treatment. It enables pathologists to identify specific genetic mutations and biomarkers associated with different types of cancer. This information helps oncologists determine the most appropriate treatment strategies, including targeted therapies and immunotherapies. The accuracy and specificity of molecular diagnostics in characterizing tumors have significantly improved cancer care and prognosis, driving the need for more comprehensive molecular pathology services.

The growth of molecular diagnostics is also intertwined with advancements in technology. New techniques and tools for molecular analysis, such as next-generation sequencing and polymerase chain reaction (PCR), have made it possible to examine genetic and molecular alterations in tissues with unprecedented precision and speed. These technological advancements have expanded the scope and capabilities of molecular pathology, making it an indispensable component of modern healthcare.

Key Market Challenges

Reimbursement Issues

One of the primary concerns in the anatomic pathology market is the uncertainty surrounding reimbursement rates. Pathology services encompass a wide range of diagnostic tests, including histopathology, cytology, and molecular diagnostics, which often involve the use of sophisticated technologies and equipment. However, reimbursement rates for these services may not always reflect the true cost incurred by laboratories, particularly in cases where advanced diagnostic techniques are employed. This disparity between the cost of providing services and the reimbursement received can strain the financial viability of pathology laboratories, hampering their ability to invest in state-of-the-art equipment and technologies.

Moreover, the complexity of reimbursement systems and the variation in policies across different regions can further compound the challenges. Navigating the intricacies of billing, coding, and documentation requirements can be time-consuming and resource-intensive for pathology laboratories. This administrative burden not only adds overhead costs but can also lead to delays in reimbursement, affecting the cash flow of these facilities.

The impact of reimbursement issues extends beyond pathology laboratories; it can also influence patient access to advanced diagnostic services. When laboratories are constrained by inadequate reimbursement rates, they may be reluctant to offer certain tests or invest in the latest technologies.

Data Privacy and Security

The Global Anatomic Pathology Market, which revolves around the examination of tissues and cells at a microscopic level to diagnose diseases, faces a significant hurdle in the form of data privacy and security concerns. In an era where digital technologies are revolutionizing the healthcare landscape, the safe and confidential handling of patient data is paramount. However, the complexities of ensuring robust data protection in the field of anatomic pathology present substantial challenges.

One of the foremost concerns is the need to safeguard patient privacy. Pathology laboratories routinely handle sensitive patient information, including medical histories, genetic data, and diagnostic reports. Ensuring that this data remains confidential and protected from unauthorized access is critical to maintaining patient trust and complying with data privacy regulations such as HIPAA (Health Insurance Portability and Accountability Act) in the United States. Any breach of patient data can result in significant legal and financial consequences, as well as damage to the reputation of healthcare providers and institutions.

The adoption of digital pathology, which involves the digitalization of pathology slides and the sharing of pathology data across healthcare systems, amplifies data security challenges. Securely transmitting and storing large volumes of digital pathology images and patient data is a complex undertaking. Laboratories must invest in robust cybersecurity measures to prevent data breaches and unauthorized access to digital records. These measures encompass encryption, access controls, intrusion detection systems, and regular security audits..

Key Market Trends

Rapid Advancements in Digital Pathology

Rapid advancements in digital pathology are serving as a driving force behind the burgeoning Global Anatomic Pathology Market. Digital pathology, a transformative technology, involves the digitization of traditional glass pathology slides and the analysis of tissue specimens in a digital format. This innovation has been a game-changer in the field of anatomic pathology, bringing a multitude of benefits that are accelerating its growth and adoption worldwide.

One of the most significant contributions of digital pathology is its ability to improve the accuracy and efficiency of diagnostic processes. By converting glass slides into high-resolution digital images, pathologists can access and analyze tissue specimens remotely. This enables the seamless sharing of pathology slides across geographical boundaries, facilitating consultations with experts from different parts of the world. The collaborative nature of digital pathology not only enhances the quality of diagnostic decisions but also expedites patient care.

Artificial intelligence (AI) and machine learning are increasingly integrated into digital pathology platforms, opening new horizons for automation and diagnostic assistance. AI algorithms can assist pathologists in identifying abnormalities, quantifying biomarkers, and streamlining workflow processes. This trend is reducing the risk of human error, accelerating the pace of diagnosis, and ultimately improving patient outcomes. Additionally, AI-driven image analysis is enabling the identification of subtle morphological patterns and molecular markers that may be challenging to detect through traditional methods.

Furthermore, digital pathology is enabling the creation of vast digital archives of pathology data. These digital repositories allow for the retrospective analysis of pathology cases, which can lead to the discovery of new insights into disease progression and treatment outcomes. Researchers can harness this wealth of data to conduct retrospective studies and advance our understanding of various diseases, ultimately contributing to the development of more effective therapies.

Molecular Diagnostics and Personalized Medicine

Molecular diagnostics and personalized medicine are dynamic forces driving the growth of the Global Anatomic Pathology Market. These intertwined trends have revolutionized the field of anatomic pathology, offering profound insights into disease diagnosis, treatment, and patient care.

Molecular diagnostics, a cornerstone of anatomic pathology, focuses on the examination of genetic and molecular alterations within tissues and cells. This powerful approach enables pathologists to delve deep into the genetic makeup of diseases, providing precise information about their molecular characteristics. It is particularly influential in oncology, where it aids in identifying specific genetic mutations and biomarkers associated with different cancer types. This information guides oncologists in developing personalized treatment strategies, including targeted therapies and immunotherapies. As a result, patients benefit from therapies tailored to their unique genetic profiles, which often lead to more effective treatment outcomes and fewer adverse effects.

The rise of personalized medicine has dovetailed with the advances in molecular diagnostics. Personalized medicine tailors medical treatments to an individual's genetic and molecular makeup, aiming to maximize treatment efficacy while minimizing side effects. Anatomic pathology plays a pivotal role in this paradigm shift, providing the diagnostic insights necessary for personalized treatment plans. Molecular diagnostics allows pathologists to identify genetic mutations and molecular markers that influence disease progression and therapeutic responses. In addition to oncology, personalized medicine is extending its reach to other medical specialties, such as cardiology, gastroenterology, and neurology, where it is enhancing the precision and effectiveness of treatment approaches.

These trends are driving the demand for anatomic pathology services. Laboratories are increasingly offering molecular diagnostics to provide clinicians with the comprehensive information needed for personalized medicine. This shift is not only improving patient care but also expanding the market's scope and reach.

Segmental Insights

Application Insights

Based on the Application, the Disease Diagnosis emerged as the dominant segment in the global market for Global Anatomic Pathology Market in 2022. Anatomic pathology, with its expertise in examining tissues and cells at a microscopic level, is indispensable in diagnosing a wide range of diseases, including cancer, infectious diseases, autoimmune disorders, and more. As a result, disease diagnosis is a routine and essential part of healthcare, driving consistent demand for anatomic pathology services.

The global population is continually growing and aging, leading to an increased prevalence of chronic diseases and conditions. This demographic shift translates to a larger patient base requiring diagnostic services. Anatomic pathology plays a crucial role in diagnosing these diseases, making it a cornerstone of healthcare systems worldwide.

End-User Insights

Based on the End-User, the Hospitals segment emerged as the dominant player in the global market for Global Anatomic Pathology Market in 2022. Hospitals are primary healthcare institutions where patients seek diagnosis and treatment for various medical conditions. Anatomic pathology services, which involve the examination of tissues and cells for diagnostic purposes, are essential in diagnosing diseases, guiding treatment decisions, and monitoring patient progress. Given the central role of hospitals in patient care, they are the primary consumers of anatomic pathology services.

Hospitals typically serve a large and diverse patient population, including individuals with a wide range of medical conditions. This high patient volume results in a substantial demand for diagnostic services. Anatomic pathology laboratories in hospitals are equipped to handle the diverse diagnostic needs of patients, from routine histopathology examinations to specialized tests.

Regional Insights

North America emerged as the dominant player in the global Anatomic Pathology Market in 2022, holding the largest market share. North America boasts one of the most advanced healthcare infrastructures globally. The region is equipped with state-of-the-art medical facilities, cutting-edge technology, and a highly skilled workforce. This infrastructure supports the demand for anatomic pathology services, ensuring access to advanced diagnostic capabilities.

North America faces a growing burden of chronic diseases, including cancer, cardiovascular diseases, and diabetes. The prevalence of these conditions necessitates extensive diagnostic services, including anatomic pathology, for early detection, accurate diagnosis, and treatment planning.

Key Market Players

Quest Diagnostics Inc

Danaher Corporation

PHC Holdings Corporation

Laboratory Corporation of America Holdings

F. Hoffmann-La Roche AG

Agilent Technologies Inc.

Cardinal Health Inc.

Sakura Finetek USA Inc.

NeoGenomics Laboratories Inc.

BioGenex

Report Scope:

In this report, the Global Anatomic Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Anatomic Pathology Market, By Type:

• Histopathology
• Cytopathology
• Surgical Pathology
• Others

Global Anatomic Pathology Market, By Technique:

• Special Staining
• Immunohistochemistry
• Electron Microscopy
• Genetic Testing
• Others

Global Anatomic Pathology Market, By Application:

• Disease Diagnosis
• Drug Discovery and Development

Global Anatomic Pathology Market, By End-User:

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Others

Global Anatomic Pathology Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Market.

Available Customizations:

• Global Anatomic Pathology Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Anatomic Pathology Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Histopathology, Cytopathology, Surgical Pathology, Others)
  • 4.2.2. By Technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing, Others)
  • 4.2.3. By Application (Disease Diagnosis, Drug Discovery and Development)
  • 4.2.4. By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Technique
  • 4.3.3. By Application
  • 4.3.4. By End-User
  • 4.3.5. By Region

5. Asia Pacific Anatomic Pathology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Technique
  • 5.2.3. By Application
  • 5.2.4. By End-User
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Anatomic Pathology Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Technique
      • 5.3.1.2.3. By Application
      • 5.3.1.2.4. By End-User
  • 5.3.2. India Anatomic Pathology Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Technique
      • 5.3.2.2.3. By Application
      • 5.3.2.2.4. By End-User
  • 5.3.3. Australia Anatomic Pathology Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Technique
      • 5.3.3.2.3. By Application
      • 5.3.3.2.4. By End-User
  • 5.3.4. Japan Anatomic Pathology Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Technique
      • 5.3.4.2.3. By Application
      • 5.3.4.2.4. By End-User
  • 5.3.5. South Korea Anatomic Pathology Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Technique
      • 5.3.5.2.3. By Application
      • 5.3.5.2.4. By End-User

6. Europe Anatomic Pathology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Anatomic Pathology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Germany Anatomic Pathology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Spain Anatomic Pathology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User
  • 6.3.4. Italy Anatomic Pathology Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Technique
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End-User
  • 6.3.5. United Kingdom Anatomic Pathology Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Technique
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End-User

7. North America Anatomic Pathology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technique
  • 7.2.3. By End-User
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Anatomic Pathology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. Mexico Anatomic Pathology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. Canada Anatomic Pathology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User

8. South America Anatomic Pathology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technique
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Anatomic Pathology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. Argentina Anatomic Pathology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Colombia Anatomic Pathology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User

9. Middle East and Africa Anatomic Pathology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Drug Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Anatomic Pathology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. Saudi Arabia Anatomic Pathology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Drug Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. UAE Anatomic Pathology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User
  • 9.3.4. Egypt Anatomic Pathology Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Technique
      • 9.3.4.2.3. By Application
      • 9.3.4.2.4. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Iron Deficiency Anemia: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Quest Diagnostics Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Danaher Corporation
• 14.3. PHC Holdings Corporation
• 14.4. Laboratory Corporation of America Holdings
• 14.5. F. Hoffmann-La Roche AG
• 14.6. Agilent Technologies Inc.
• 14.7. Cardinal Health Inc.
• 14.8. Sakura Finetek USA Inc.
• 14.9. NeoGenomics Laboratories Inc.
• 14.10. BioGenex.

15. Strategic Recommendations

16. About Us & Disclaimer